Home › Trial NCT01158885
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
- Trial IDNCT01158885
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorTherapeutic Advances in Childhood Leukemia Consortium
- Enrollment2
- Start date2010-08
- ConditionsMinimal Residual Disease · Leukemia, Lymphoblastic, Acute · Leukemia, Myelogenous, Acute
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.